UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota

Gut, 2019-07, Vol.68 (7), p.1180-1189

2019

Volltextzugriff (PDF)

Microbiota, not host origin drives ex vivo intestinal epithelial responses

Gut microbes, 2022-12, Vol.14 (1), p.2089003-2089003

2022

Volltextzugriff (PDF)

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

iScience, 2022-05, Vol.25 (5), p.103963-103963, Article 103963

2022

Volltextzugriff (PDF)

Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2020-11, Vol.52 (9), p.1453-1468

2020

Volltextzugriff (PDF)

Whipping Crohn's With Helminth Therapies? Not Yet

Journal of Crohn's and colitis, 2017-04, Vol.11 (4), p.387-389

2017

Volltextzugriff (PDF)

Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses

Nature microbiology, 2019-11, Vol.4 (11), p.1826-1831

2019

Volltextzugriff (PDF)

Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study

Pediatric nephrology (Berlin, West), 2024-04, Vol.39 (4), p.1201-1212

2024

Volltextzugriff (PDF)

Tu1485: EXPOSURE TO MICROBIOTA FROM ULCERATIVE COLITIS PATIENTS IS INDUCING STRESS RESPONSES IN EPITHELIAL CELLS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-981-S-982

2022

Volltextzugriff (PDF)

Mo1810 – Faecal Calprotectin Concentration in Inflammatory Bowel Disease and Controls: the Impact of Storage Time and Freeze-Thaw Cycles

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-846-S-846

2019

Volltextzugriff (PDF)

Mo1926 – A Single Center Experience: Fecal Microbiota Transplantation As Treatment for Recurrent Clostridium Difficile Infections

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-889-S-889

2019

Volltextzugriff (PDF)

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis

Journal of Crohn's and colitis, 2023-10, Vol.17 (9), p.1504-1513

2023

Volltextzugriff (PDF)

Su1199 THE IMPACT OF BIOLOGICAL TREATMENT AND INFLAMMATORY BURDEN IN INFLAMMATORY BOWEL DISEASE ON THE GUT MICROBIOTA

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-540-S-540

2020

Volltextzugriff (PDF)

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-176-S-177

2024

Volltextzugriff (PDF)

The human microbiome in health and disease: hype or hope

Acta clinica belgica (English ed. Online), 2019-03, Vol.74 (2), p.53-64

2019

Volltextzugriff (PDF)

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Clinical gastroenterology and hepatology, 2024-05

2024

Volltextzugriff (PDF)

Tu1789 – Treatment Response to Ustekinumab and Vedolizumab in Inflammatory Bowel Disease: the Predictive Role of Gut Microbiota

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1124-S-1124

2019

Volltextzugriff (PDF)

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-919-S-920

2023

Volltextzugriff (PDF)

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-95-S-96

2022

Volltextzugriff (PDF)

RIGOROUS DONOR SELECTION FOR FMT IN ACTIVE ULCERATIVE COLITIS: KEY LESSONS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Clinical gastroenterology and hepatology, 2024-05

2024

Volltextzugriff (PDF)

1122 Affective Disorders, Somatization and Body Awareness are Associated With Positive Symptom Association During 24 Hour Impedance-pH Monitoring in Patients With Reflux Symptoms

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-204-S-204

2012

Volltextzugriff (PDF)

Determinants of Symptom Perception During Impedance-pH Monitoring: Do Psychosocial Factors and ‘Somatization’ Play a Role?

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-246-S-246

2011

Volltextzugriff (PDF)

Integrated Analysis of Microbe-Host Interactions in Crohn's Disease Reveals Potential Mechanistic Effects of Microbial Proteins on Host Gene Expression

SSRN Electronic Journal

Volltextzugriff (PDF)

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1208-S-1208

2020

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Life Sciences & Biomedicine
(8)
Humans
(6)
Microbiota
(6)
Gastroenterology & Hepatology
(5)
Gastrointestinal Microbiome
(4)
Microbiomes
(4)
Feces - Microbiology
(3)
Female
(3)
Inflammatory Bowel Diseases - Microbiology
(3)
Intestinal Microflora
(3)
Intestine
(3)
Male
(3)
Microbiome
(3)
Middle Aged
(3)
Treatment Outcome
(3)
Adult
(2)
Bacteria
(2)
Digestive System
(2)
Digestive Tract
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota

Microbiota, not host origin drives ex vivo intestinal epithelial responses

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease

Whipping Crohn's With Helminth Therapies? Not Yet

Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses

Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study

Tu1485: EXPOSURE TO MICROBIOTA FROM ULCERATIVE COLITIS PATIENTS IS INDUCING STRESS RESPONSES IN EPITHELIAL CELLS

Mo1810 – Faecal Calprotectin Concentration in Inflammatory Bowel Disease and Controls: the Impact of Storage Time and Freeze-Thaw Cycles

Mo1926 – A Single Center Experience: Fecal Microbiota Transplantation As Treatment for Recurrent Clostridium Difficile Infections

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis

Su1199 THE IMPACT OF BIOLOGICAL TREATMENT AND INFLAMMATORY BURDEN IN INFLAMMATORY BOWEL DISEASE ON THE GUT MICROBIOTA

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

The human microbiome in health and disease: hype or hope

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Tu1789 – Treatment Response to Ustekinumab and Vedolizumab in Inflammatory Bowel Disease: the Predictive Role of Gut Microbiota

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

RIGOROUS DONOR SELECTION FOR FMT IN ACTIVE ULCERATIVE COLITIS: KEY LESSONS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

1122 Affective Disorders, Somatization and Body Awareness are Associated With Positive Symptom Association During 24 Hour Impedance-pH Monitoring in Patients With Reflux Symptoms

Determinants of Symptom Perception During Impedance-pH Monitoring: Do Psychosocial Factors and ‘Somatization’ Play a Role?

Integrated Analysis of Microbe-Host Interactions in Crohn's Disease Reveals Potential Mechanistic Effects of Microbial Proteins on Host Gene Expression

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Suchergebnisse filtern